AtriCure Inc. (ATRC) PT Lowered to $58 at UBS
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $45.76 +2.21%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
UBS analyst Danielle Antalffy lowered the price target on AtriCure Inc. (NASDAQ: ATRC) to $58.00 (from $60.00) while maintaining a Buy rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Grocery Outlet Holding (GO) PT Raised to $12 at TD Cowen
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
